A Study of Lerociclib in Participants With Advanced Breast Cancer

Clinical trial NCT05085002 · TERMINATED

Trial details

NCT number: NCT05085002
Sponsor: EQRx, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2021-12-21
Primary completion: 2023-11-29
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.